Adjusted EBITDA hit a record $32.4 million, representing 16% of revenue, an 80 basis point expansion from the prior year, continuing momentum toward the VISION 2027 goal of 18%.
Consolidated backlog stood at $1.02 billion, down $50 million year-over-year due to timing of awards; defense backlog was flat at $593 million, commercial aerospace backlog declined by $47 million.
Ducommun reported Q2 2025 revenue of $202.3 million, a 2.7% increase year-over-year, marking the 17th consecutive quarter of revenue growth and setting a new quarterly record.
GAAP diluted EPS was $0.82 compared to $0.52 in Q2 2024; adjusted diluted EPS was $0.88 versus $0.83 prior year, driven by higher operating income and lower interest expense.
Gross margin reached a record 26.6%, up 60 basis points year-over-year, supported by engineered product portfolio growth, pricing initiatives, and productivity improvements.
Military and space segment revenue grew 16% driven by missile and radar programs, while commercial aerospace revenue declined 10% due to lower Boeing build rates and destocking.
Adjusted EBITDA was $39 million, a $46 million decrease from the prior year, with a margin of 4.7%, impacted by lower volumes, unfavorable mix, and cost pressures.
Europe segment revenue decreased 2.7% to $268 million with adjusted EBITDA of $17 million, down $3 million year-over-year.
Free cash flow was negligible compared to $12 million in Q2 2024, driven by lower EBITDA despite positive working capital generation.
JELD-WEN reported Q2 2025 revenue of $824 million, down 16% year-over-year, primarily due to a 14% volume decline and the court-ordered divestiture of the Towanda operation.
Net debt leverage ratio increased to 5.7x due to lower sales volume and EBITDA, exceeding the targeted range.
North America segment revenue declined 22% to $556 million with adjusted EBITDA falling to $35 million from $76 million last year.